Notably, the protein targets such as epidermal growth factor receptor (EGFR), mitogen-activated protein kinase 1 (MAPK1) and mitogen-activated protein kinase 3 (MAPK3) were found to maximally participate in >10 cancer pathways. This evidence concerns the gene MAP2K3 and cancer.